Viewing Study NCT02125318


Ignite Creation Date: 2025-12-25 @ 4:31 AM
Ignite Modification Date: 2026-03-01 @ 9:31 PM
Study NCT ID: NCT02125318
Status: COMPLETED
Last Update Posted: 2017-02-27
First Post: 2014-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders
Sponsor: Galena Biopharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module